The work, performed in collaboration with the Perelman School of Medicine and School of Veterinary Medicine, as well as The Wistar Institute and Fraunhofer USA, could lead to a low-cost tool in the arsenal against the COVID-19 pandemic. Their study appeared in Molecular Therapy.
“SARS-CoV-2 replicates in the salivary glands, and we know that when someone infected sneezes, coughs, or speaks some of that virus can be expelled,” says Daniell. “Indeed, speaking four words releases more virus particles than breathing without a mask for one hour. This gum offers an opportunity to neutralize the virus in the saliva, giving us a simple way to possibly cut down on a source of transmission.”
Pre-pandemic, Daniell was studying the angiotensin-converting enzyme 2 (ACE2) protein in the context of treating hypertension. His lab had grown this protein, as well as many others that may have therapeutic potential, using a patented plant-based production system. The plant material, freeze-dried and ground-up, could be used to deliver the protein.
Daniell’s past work on ACE2 proved fortuitous in the context of the COVID-19 pandemic. The receptor for ACE2 on human cells also happens to bind the SARS-CoV-2 spike protein and ACE2 enzyme is naturally present in saliva. Meanwhile, another line of work by Daniell involved research to develop a chewing gum infused with plant-grown enzymes to disrupt dental plaque. Pairing his insights about ACE2 with this technology, Daniell wondered if such a gum, infused with plant-grown ACE2 proteins, could neutralize SARS-CoV-2 in the oral cavity.
To find out, he contacted Ronald Collman at Penn Medicine, whose team had been collecting biospecimens from COVID patients for research. To test the gum, the team grew ACE2 in plants, paired with another compound that enables the protein to block gates of viral entry and incorporated the resulting plant material into cinnamon-flavored gum tablets. Among various tests, the team exposed saliva samples from COVID-19 patients to the ACE2 gum and found that levels of viral RNA fell so dramatically to be almost undetectable.
The research team is currently working toward obtaining permission for a clinical trial to evaluate safety and efficacy when tested in people infected with SARS-CoV-2.
Source: https://www.dental.upenn.edu/
Editorials 14 November 2025
Penn Dental Medicine shared its expertise in caring for persons with disabilities with dental care providers from throughout Jamaica at a 1 ½ -day hands-on continuing education program, held October...
Editorials 23 July 2025
The Center for Innovation & Precision Dentistry (CiPD) at Penn Dental Medicine proudly hosted its Fourth Annual CiPD Symposium on May 29 bringing together a dynamic community of dentists,...
Oral healthcare providers and patients will soon receive more frequent, evidence-informed recommendations to advance oral and overall health with the establishment of the ADA Living Guideline...
Editorials 26 May 2025
Groundbreaking program to provide evidence-informed guidelines in real time to support patient care and advance public health
Editorials 03 February 2025
White Coat Ceremony Welcomes New Class of Foreign Trained Dentists to Penn Dental Medicine
Penn Dental Medicine welcomed 38 foreign-trained dentists to the study of dental medicine as part of the DMD Class of 2027 with its White Coat Ceremony, held January 8 at Penn Dental Medicine.
Products 18 November 2026
News 18 November 2026
Angelalign Technology Appoints Marco Gadola as Senior Advisor
(6699.HK) (“Angel”), a global clear aligner leader, recently announced that Marco Gadola has joined the company as Senior Advisor.
News 18 November 2026
(“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exo
Editorials 18 November 2026
The Pediatric Dentistry Alumni Association supports the IU Pediatric Dentistry Department and students in a variety of ways.
Orthodontics 18 November 2026
This peer-reviewed orthodontics article summarizes clinical evidence from Dental press journal of orthodontics (2024). It focuses on findings that may help dental professionals evaluate treatment...